SCHEMBL10169294

SCHEMBL10169294

O=C(Cc1ccc(-c2ccc(CN3CCOCC3)cc2F)nc1)NCc1cccc(P)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 3/20 0.44
MCHR1 Q99705 2/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
JAK3 P52333 1/20 0.41
CHRM3 P20309 1/20 0.41
HTT P42858 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
BDKRB1 P46663 1/20 0.40
ADORA2A P29274 1/20 0.39
HTR2C P28335 1/20 0.39
KMT2A Q03164 1/20 0.39
ERCC1 P07992 1/20 0.39
ERCC4 Q92889 1/20 0.39
USP2 O75604 1/20 0.39
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11917500 0.92 SRC (0.53) SRCMCHR1JAK2JAK1TYK2
SCHEMBL11917505 0.91 ALDH1A1 (0.50) SRCMCHR1JAK2JAK1TYK2
SCHEMBL12782522 0.90 SMN1; SMN2 (0.44) SRCMCHR1JAK2JAK1TYK2
SCHEMBL254389 0.83 SRC (0.54) SRCMCHR1CHRM3HTTNPC1
SCHEMBL254561 0.82 ALDH1A1 (0.54) SRCMCHR1CHRM3HTTNPC1
SCHEMBL12782469 0.81 LMNA (0.47) SRCMCHR1JAK2JAK1TYK2
SCHEMBL16572268 0.80 SRC (0.56) SRCMCHR1HTTNPC1RAB9A
SCHEMBL11917498 0.79 SRC (0.66) SRCEPHX2ABL1TUBB4ATUBB
SCHEMBL13096530 0.79 CHRM4 (0.43) MCHR1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL254626 0.79 SRC (0.56) SRCMCHR1JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836169-B9 COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS KINEX PHARMACEUTICALS LLC (US) 2012-07-04 EP disclosed
EP-1836169-B1 COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS KINEX PHARMACEUTICALS LLC (US) 2012-02-08 EP disclosed